lecithin:cholesterol acyltransferase; LTQ/Orbitrap, a linear ion trap combined with an Orbitrap analyzer mass spectrometer; ONL, outer nuclear layer; ROS, rod outer segment; RPE, retinal pigment epithelium; RPLC, reverse-phase liquid chromatography; SREBP, sterol regulatory element-binding protein; SLOS, Smith-Lemli-Opitz Syndrome; Stat3, signal transducer and activator of transcription 3; TFA, Tris-formic acid; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
INTRODUCTION
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder associated with subnormal growth and failure to thrive, mental retardation and neurosensory deficits, and multiple congenital anomalies, including dysmorphologies (1, 2) . Early epidemiological studies estimated the incidence of SLOS to be 1 in 20,000 to 1 in 60,000 live births, primarily among Caucasians (1, 2) . However, more recent studies suggest the SLOS carrier frequency to be approximately 1 in 30 to 1 in 50; this predicts a much higher actual disease frequency, ranging from 1 in 1,590 to 1 in 17,000 (3, 4) , making SLOS the fourth most common autosomal recessive human disease (after cystic fibrosis, phenylketonuria, and hemochromatosis). Mutation of the DHCR7 gene is the intrinsic cause of SLOS; this gene encodes the enzyme DHCR7 (3β-hydroxysterol-7-reductase, a.k.a. 7-dehydrocholesterol reductase; EC1.3.1.21), which catalyzes the final step in the cholesterol biosynthetic pathway, i.e., reducing the 7 double bond and, thus, converting 7-dehydrocholesterol (7DHC) to cholesterol (4, 5) . As a consequence, markedly reduced levels of cholesterol and aberrantly elevated levels of the cholesterol precursor 7DHC (and its epimer, 8DHC) are observed in the majority of affected SLOS patients (6, 7) . Therefore, the clinical suspicion of SLOS is confirmed by demonstrating elevated 7DHC in plasma or tissues, typically by chromatographic methods, e.g., HPLC or gas chromatography/mass spectrometry (GC/MS) (8, 9) .
Visual capacity may become compromised in SLOS patients due to a variety of congenital or postnatal pathologies, such as cataracts, aniridia, corneal endothelium defects, sclerocornea, electrophysiological defects in the retina, optic nerve abnormalities, or other ophthalmologic problems (10, 11) . While we currently lack full knowledge of the exact pathobiological mechanism underlying SLOS, additional insights may be afforded by studies employing a rodent model of the disease that has been developed by treatment of rats with AY9944 (trans-1,4-bis [2- chlorobenzylaminomethyl] cyclohexane dihydrochloride), a relatively selective inhibitor of DHCR7 (12) (13) (14) . We previously have described progressive retinal degeneration in this rat model of SLOS, which is characterized by shortening of retinal rod outer segments (ROS), pyknosis and thinning of the outer nuclear layer (ONL) of the retina (which contains the photoreceptor nuclei), and accumulation of membranous/lipid inclusions in the retinal pigment epithelium (RPE) (12, 13) . Reduced ROS membrane fluidity primarily caused by a dramatic (30-40 mol%) decline in docosahexaenoic acid (DHA; 22:6, n3) levels, relative to age-matched controls, also was observed in the SLOS rat model by three postnatal months (15, 16) . Retinal function and sterol steady-state in the same rat model of SLOS can be partially rescued using a high-cholesterol diet (2%, by wt.), although histological degeneration of the retina still occurs (17) . However, the molecular mechanisms that underlie the observed electrophysiological defects in the retina, the accumulation of membranous/lipid inclusions in the RPE, the shortening of retinal ROS, and the initiation of ONL pyknosis in the SLOS rat model remain poorly understood. Therefore, a comprehensive profiling of the retinal proteomes of AY9944-treated vs. age-matched untreated control rats may contribute to a further understanding of the underlying mechanisms responsible for the retinopathy associated with the SLOS model, by extension, with the human disease as well.
Nevertheless, extensive and reliable expression profiling of the retinal proteome remains a prominent challenge, owing to the need to quantify multiple animals and a high percentage of integral membrane and membrane-associated proteins (26, 27) . Label-free approaches can compare multiple replicates (18) (19) (20) with quantitative accuracy comparable to stable isotopelabeling methods (21) (22) (23) . However, in order to achieve reliable relative quantification, highly quantitative and reproducible sample preparation and LC/MS analysis are required for relatively large-scale sample cohorts.
In the present study, we performed a reproducible, well-controlled, and ion-current-based comparative proteomic analysis of the retinas from AY9944-treated vs. age/sex-matched control rats (N=5 animals each). A high-concentration detergent cocktail was used for efficient extraction of proteins from retinas, followed by a reproducible precipitation/on-pellet-digestion procedure and long-column, 7-h nano-LC-MS analysis. These approaches ensured extensive comparative analysis of retina samples with 10 animals. The preparative and analytical procedures were carefully optimized and controlled to ensure optimal reproducibility. The performance of two label-free approaches, the ion current-based and spectral counting methods, were compared in parallel. The altered proteins were subjected to functional annotation, and selected groups of proteins of interest were further validated by Western blot and correlative immunohistochemical (IHC) analysis.
EXPERIMENTAL PROCEDURES

Materials and Reagents-Please see Supplemental Experimental Procedures section.
Treatment of Animals-The SLOS rat model was generated essentially as previously described by Fliesler et al. (12) , with the modifications as described by Fliesler et al. (17) . For each treatment vs. control comparison, all animals were age-and sex (male)-matched. All procedures involving animals were approved by the Buffalo VAMC and University at Buffalo Institutional Animal Care and Use Committees (IACUCs), and were in accordance with the
ARVO Resolution on the Use of Animals in Research and with the NIH Guide for the Ca re and
Use of Laboratory Animals.
Tissue Preparation and Precipitation/on-pellet Digestion-Each isolated retina was homogenized in 400 µL of ice-cold lysis buffer (50 mM Tris-formic acid (TFA), 150 mM NaCl, 0.5% sodium deoxycholate, 2% SDS, 2% NP-40, pH8.0) with a Polytron homogenizer (Kinematica AG, Switzerland). Homogenization was performed for 5-10 s at 15,000 rpm, followed by a 20-s cooling period until the foam settled; then this procedure was repeated 10 times. The mixture was then sonicated with a low-power bath sonicator in a cold room (4C ) for ~10 min, at which point the solution was clear, followed by centrifugation at 140,000 x g for 1 h at 4C. The supernatant was carefully transferred to a fresh tube, sealed, and stored at -80C until ready for analysis. In order to remove undesirable components in the samples while maintaining high peptide recovery, we employed a precipitation/on-pellet-digestion protocol modified from that described previously (29) and the details are shown in Supplemental Experimental
Procedures.
Nano-RPLC/Mass Spectrometry-The nano-RPLC (reverse-phase liquid chromatography) system consisted of a Spark Endurance autosampler (Emmen, Holland) and an ultra-high pressure Eksigent (Dublin, CA) Nano-2D Ultra capillary/nano-LC system. To achieve a comprehensive separation of the complex peptide mixture, a nano-LC/nanospray setup, which features low void volume and high chromatographic reproducibility (29) , was employed. Mobile phase A and B were 0.1% formic acid in 2% acetonitrile and 0.1% formic acid in 88% acetonitrile, respectively.
Samples (each containing 6 µg of total peptides) were loaded onto a large-ID trap (300 µm ID x1 cm, packed with Zorbax 3-µm C18 material) with 1% mobile phase B at a flow rate of 10 µL/min, and the trap was washed for 3 min. A series of nanoflow gradients (flow rate, 250 nL/min) was used to back-flush the trapped samples onto the nano-LC column (75 µm ID x 75 cm, packed with Pepmap® 3-µm C18 material) for separation. Heating the nano-LC column at 52°C greatly improved both chromatographic resolution and reproducibility. A 7-h gradient was used to resolve the complex peptide mixture, which consisted of the following steps: 3% B for 10 min, transitioning over 5 min to for 3-8% B in 5 min, 8-24% B in 145 min, 38% B over 95 min, 38-63% B over 55 min, 97% B in 35 min, then maintaining isocratic conditions at 97% B for 25 min, and finally reverting back to 3% B and holding for 40 min. In order to maintain stabilized ionization efficiency, the spray tip was washed by dripping 50% methanol by gravity after every three runs.
An LTQ/Orbitrap-ETD hybrid mass spectrometer (Thermo Fisher Scientific, San Jose, CA) was used for protein identification. The instrument was operated in data-dependent product ion mode. One scan cycle included an MS1 scan (m/z 300-2000) at a resolution of 60,000 followed by seven MS2 scans in CID activation mode, to fragment the seven most abundant precursors found in the MS1 spectrum. The target value for MS1 by Orbitrap was 7×10 6 , under which the Orbitrap was calibrated carefully for mass accuracy and FT transmission. The use of high target value on the Orbitrap enabled a highly sensitive detection without compromising the mass accuracy and resolution. The activation time was 30 ms, the isolation width was 1.5 Da for the linear ion trap (LTQ), the normalized activation energy was 35%, and the activation q was 0.25.
Five biological replicates of each biological group (AY9944-treated vs. control) were analyzed randomly; in addition, 10 replicates of "Sham" samples (equal mixture of AY9944-treated and control material) were analyzed to assess the quantitative reproducibility and precision of the procedure. Therefore, in total, 20 nano-LC/MS runs of the biological and Sham groups were performed in a randomly-interleaved sequence.
Protein Identification-Individual data files were searched against the Swiss-Prot rat protein database (version 06/13/2012) with a total of 7,766 protein entries, using the Proteome Discoverer 1.2 (Thermo-Scientific). The search parameters used were as following: 25 ppm tolerance for precursor ion masses and 1.0 Da for fragment ion masses. Two missed cleavages were permitted for fully tryptic peptides. Carbamidomethylation of cysteines was set as a fixed modification, and a variable modification of methionine oxidation was allowed. The false discovery rate was detected by using a target-decoy search strategy (31) . The sequence database contains each sequence in both forward and reversed orientations, enabling false discovery rate (FDR) estimation. Scaffold 3.6 (32) (Proteome Software, Portland, OR), capable of handling large-scale proteomic datasets, was used to validate MS/MS-based peptide and protein identification based on cross-correlation (Xcorr) and Delta Cn values. The peptide filtering criteria include Delta Cn scores of > 0.1 and Xcorr scores of > 1.7, 1.9, 2.3 and 2.5, respectively, for singly, doubly, triply and quadruply charged peptides. Stringent cutoffs for the Delta Cn scores and Xcorrs, along with the requirement that least two distinct peptide sequences were identified for each protein, resulted a low false discovery rate (FDR=0.4% at the peptide level).
Protein Quantification and evaluation-Ion current based quantitative analysis was performed using SIEVE® v2.0 software (Thermo Scientific, San Jose, CA) to obtain area-underthe-curve (AUC) data, and then a sum-intensity method to aggregate the quantitative data from peptide level to protein level. SIEVE® is a label-free differential expression package that includes chromatographic alignment and global intensity-based MS1 feature extraction (33). The SIEVE® package processed chromatographic alignment between LC-MS/MS runs with the ChromAlign algorithm (34) . To achieve excellent quality control of LC-MS/MS runs, the alignment scores and base-peak-ion-current intensity were closely monitored and benchmarked during sample runs. Subsequently, quantitative "frames" were defined based on m/z and retention time in the aligned collective data set. In order to ensure the reliability of quantification, only frames with high-quality AUC data (e.g. S/N>10) were used for quantification. Peptide ion current areas were calculated for each frame. Subsequent to relative quantification, MS2 fragmentation scans associated with each frame were identified by importing the msf files created by Proteome Discoverer (cf. the protein identification procedure). Peptides shared among different protein groups were excluded from quantitative analysis. The ion current intensities of each protein were normalized by the total AUC in each individual run. Statistical significance between groups (comparing treated vs. control specimens) was evaluated using a Student's t-test, with a p-value cutoff of 0.05. The relative expression ratio was calculated by the average ioncurrent intensities of five replicates in each group.
To estimate quantitative variability arising from technical aspects, we analyzed 10 replicates of the same pool sample along with the analysis of the AY9944-treated vs. control data set (cf. Immunohistochemistry-Eyes were dissected from freshly euthanized rats and fixed by immersion for 24 h in a solution of 4% formaldehyde (prepared freshly from paraformaldehyde; Electron Microscopy Sciences, Hatfield, PA) in Dulbecco's phosphate-buffered saline (PBS) at 4C, and processed for conventional paraffin embedment. Tissue sections (6-m thickness) were collected on ProbeOn Plus™ glass microscope slides (Fisher Scientific, Pittsburgh, PA), then deparaffinized and rehydrated with PBS. Antigen retrieval was carried out essentially as described by Shi et al. (35) Slides were placed into 50-ml conical polypropylene tubes containing 10 mM sodium citrate, pH 6.1 (preheated in boiling water), then heated in a boiling water bath for 
TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) assay-
Following deparaffinization and rehydration (see above), rat retina tissue sections on glass microscope slides were permeabilized by incubation for 1 h at room temperature with Neuropore® (R&D Systems, Minneapolis, MN), then rinsed with PBS. Sections were then processed for the TUNEL assay, essentially as described by Gavrieli et al. (36) , using the DeadEnd™ Fluorimetric TUNEL System (Promega, Madison, WI) according to the directions provided by the manufacturer. Briefly, sections were equilibrated with assay buffer, and then incubated for one hour at 37°C with nucleotide mix containing dATP, fluorescein-tagged dUTP, and recombinant terminal deoxynucleotidyl transferase (rTdT). The reaction was stopped by immersion of the slides in saline citrate buffer; the slides were rinsed and coverslipped as for immunohistochemistry (see above). Positive controls consisted of normal rat retinal tissue sections (nominally "TUNEL-negative"; see Results) exposed to DNase prior to the TUNEL reaction; negative controls were either AY9944-treated rat or DNase-treated normal tissue sections processed for TUNEL assay, but with omission of rTdT (data not shown).
Bioinformatics Analysis-Protein function and pathway analyses were carried out using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, http://www.ingenuity.com/). Ingenuity's knowledge base is created by manual curation of the scientific literature supported by experimental results that are structured into an ontological relational database. We analyzed the data set of 101 differentially-expressed proteins determined by the ion-current-based method. The data set was imported directly into IPA for a Core analysis. Biological functions assigned by the software were manually examined, and re-grouped into respective categories. Hierarchical cluster analysis was performed using Cluster 3.0 (37) and displayed by TreeView (Java software), which supports tree-based and image-based browsing of hierarchical trees (http://www.eisenlab.org). In the heat map generated by TreeView, the elevated protein intensities are indicated in red, and the decreased protein intensities are indicated in green.
RESULTS
The development and evaluation of the ion current based procedure for profiling of retinal proteome.
In order to achieve a reliable discovery of altered proteins for the AY9944-induced retinal degeneration in the SLOS rat model, we developed a reproducible, extensive and well-controlled proteomic strategy (see schematic Fig. 1 ) for the profiling of the retinal proteome with 10 animals.
All samples were prepared and analyzed in a random order to obviate analytical bias. Each of the following steps was thoroughly optimized and evaluated.
i) Efficient and quantitative retinal protein extraction, sample cleanup and digestion. The retina is a highly ordered tissue with various anatomical layers, cell types and subcellular compartments containing numerous hydrophobic membrane proteins (38) ; hence, it is challenging to extract the membrane-bound proteins efficiently and quantitatively. To address this problem, we homogenized retinas using a Polytron tissue homogenizer in a "strong" buffer containing a cocktail of detergents (2% NP-40, 2% SDS and 0.5% sodium deoxycholate), which has been previously demonstrated by our lab to efficiently extract proteins from biological tissues, including membrane proteins (20, (28) (29) (30) . The extracted proteins were subjected to a quantitative precipitation/on-pellet-digestion procedure (20, 29, 39) to remove detergents and other nonprotein components, and then completely digest the extracts. Under the optimized conditions, high, reproducible protein yields were achieved (Supplemental Fig. 1A ). The completeness of extraction was confirmed by the observation that <0.5% of the total proteins were detected in the residue tissue pellets (data not shown). After digestion, the mean peptide recovery was 80.5% with a RSD of 11.9% (N=10, determined by a modified BCA method (29)), and day-to-day reproducibility was excellent as well (Supplemental Fig. 1B) . Among the proteins analyzed in this study, a total of 473 (40.5%) proteins out of the 1,167 proteins with available GO Cellular Location information were assigned as membrane (i.e., highly hydrophobic) proteins, indicating the good recovery of membrane proteins.
ii) Reproducible and sensitive nano-LC/MS analysis with an extensive chromatographic separation.
We developed and optimized a high-resolution and reproducible chromatographic strategy, which permits an extensive and reliable quantification of the retinal proteome with multiple biological replicates. The run-to-run reproducibility was assessed by performing 10 consecutive analyses of a pooled retina sample over a 3-day period. Ten representative peptides that were randomly selected within each 30-min segment of the elution window were used for the evaluation. Low variations of 0.3-0.7% and 5.8-14.8% for the retention times and area-under-thecurves (AUC), respectively, across the 10 peptides were achieved. We also assessed the quantitative reproducibility on protein levels using both the ion-current-based and the spectral counting methods. Some representative data are shown in determined by the ion-current-base method, were ~1/3 of these of spectral counting, at 11.2% for ion-current-based method vs. 32.2% for spectral counting method (Supplemental Fig. 2 ).
Moreover, it is interesting to observe that the ion-current-based method provided far superior precision in measuring lower-abundance proteins (i.e. these with low spectral counts or AUC, Fig.   2 ). Finally, the results also suggest for this particular study, the quantitative dynamic range of the ion-current-based method may be wider than the spectral counting approach by 2 orders of magnitude.
We also compared the extent of false discovery arising only from the technical variability, by the ion-current-based method vs. spectral counting. Among the 10 consecutive analyses of a pooled retina sample (i.e. the Sham set, c.f. the Experimental Procedures and Fig. 1 ), we designated five randomly-selected aliquots as the "Sham-control samples", while the remaining five were designated as the "Sham-experimental samples". Four and 26 proteins, respectively, exhibited statistical significance (p<0.05) for ion current-based and spectral counting approaches (Supplemental Tables I and II) . The median relative standard deviations (RSD) of protein ratios were 9.8% and 27.1% by ion current and spectral counting methods, respectively (Supplemental Tables I and II) . Using the cutoff criteria of 30% changes to either direction and p<0.05, zero and 16 proteins, respectively, were determined as altered proteins by ion current-based and spectral counting approaches respectively. We also compared 5 control animals with equal number of controls, and found similar trend of false-positives (data not shown). Obviously, in this study, the ion current-based method showed a markedly lower level of false-positive discovery of altered proteins, due to its higher quantitative precision as shown previously. As a result, we chose the ion current-based method over the spectral counting approach in this study.
Significantly altered proteins in retinas from SLOS model rats vs. age-matched controls.
Since one of the purposes of this study is to discovery altered proteins with high confidence, a set of stringent cutoff criteria were applied so that only protein/peptides with high-quality AUC data are quantified. These include high cutoff criteria for peptides identification, strict criteria for peak detection and frame generation (e.g., signal-to-noise ratio (S/N)>10), and that each quantifiable protein were required to have at least two independent sets of qualified AUC data from distinct peptides (cf., Experimental Procedures). Furthermore, shared peptides among different proteins were removed from quantitative analysis. Under the criteria, 1,259 unique protein groups were quantified in the AY9944 vs. control sample set, which encompass the quantification of the ion-currents from 9817 unique peptides. For both the AY9944 vs. control sample set and the sham sample set, there were no missing data in any replicate on the protein level. In this study, the cutoff criteria of 30% changes to either direction and p<0.05 (AY9944-treated vs. control group) were employed for differential expression analyses based on the estimation of false-positives (shown above). As a result, 101 proteins were determined as altered.
The mean value of sequence coverage of 1259 proteins analyzed in this study is 27.9%
(Supplemental Table III ). The biological variation among retinas from AY9944-treated vs.
control rats (N=5 each) was evaluated as well. The mean values of coefficient variation (CV) of ion current areas for all quantified proteins were 16.0% and 14.0%, respectively in the five AY9944-treated animals and five controls. Of the 101 differentially expressed proteins determined by the ion current-based approach (Supplemental Table IV ), 58 were elevated and 43 were decreased in retinas from the AY9944-treated group compared to the age-matched control group. Fig. 3 shows a heat map plot of the intensities of altered proteins in the 10 biological samples, which illustrates the significant change of the 101 proteins between AY9944-treated and control animals. As indicated in the "tree" diagrams, five AY9944-treated samples and five controls were classified into the corresponding clusters as expected. These changes in protein abundance are also reflected in the "volcano" plots (fold change vs. p-values) of the AY9944/control set (Supplemental Fig. 3 ). By comparison, in the sham set the vast majority of proteins showed a ratio close to one with no altered proteins discovered, which further illustrates the high accuracy and reproducibility of the overall proteomics strategy. The ratios of peptides from altered proteins were further investigated (see Supplemental Table V ). The distribution of peptide ratios assigned to altered proteins is shown in Supplemental Fig. 4 . Out of the 368 unique peptides assigned to the 58 elevated proteins, the majority of them (351, 95.4%) had an elevated expression ratio (Supplemental Fig. 4A ). For a randomly selected example: glial fibrillary acidic protein (GFAP), one of the more profoundly altered proteins, was determined as elevated and quantified with 26 distinct peptides; of these peptides, 25 (96.2%) of them had relative ratios > 1.3 (Supplemental Table V) . A similar trend was observed for the peptides in decreased proteins (Supplemental Fig. 4B ). This result demonstrates that corresponding peptide ratios agree well with the protein ratios achieved in this study.
Moreover, we compared the relative expression ratios of these 101 proteins obtained by spectral counting (Supplemental Table VI ) and ion current-based approaches. Interestingly, the ratios determined by the two methods showed strongly significant correlation for the altered proteins (Pearson's correlation coefficient=0.81, p<0.001), as specified in Supplemental Fig. 5 .
Furthermore, the levels of "housekeeping" proteins, such as beta-tubulin, actin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which are often used as the loading controls for SDS-PAGE and Western blot analysis, remained unchanged between the two groups (Supplemental Fig. 6 ) as determined by both the ion-current-based and the spectral counting methods.
Functional annotation and validation of proteins of high interest.
The 101 altered proteins were assigned to 10 major categories of biological processes using 5A ). The means of intensities in control retinas were normalized to 1.0 for both Western blot assay and ion current-based quantification, and were found to be consistent with one another (Fig.   5B ).
b) Oxidative Stress Response. We found 9 significantly-altered proteins relevant to oxidative stress responses (Supplemental Table IV (Fig. 7B) ; by contrast, untreated control retinas exhibited only occasional TUNEL-positive cells (Fig. 7A) . Since the ONL normally contains the nuclei of only the rod and cone photoreceptor cells, these findings are consistent with the observed retinal degeneration in the SLOS rat model (12, 43) . Notably, TUNEL-positive labeling was restricted almost exclusively to the ONL, suggesting that photoreceptor cells are somehow selectively (or more highly) sensitive to the associated cytotoxic effects of AY9944 treatment. In addition, glial fibrillary acidic protein (GFAP), a sensitive marker for activation and hypertrophy of glia (a.k.a. gliosis) as occurs in various types of retinal degeneration (44, 45) , was found to be highly expressed in retinas of AY9944-treated rats by ion-current-based profiling (Fig. 3) . (46, 47) . In this study, we found that the levels of pro-cathepsin D, intermediate form and mature enzyme were substantially higher in retinas of AY9944-treated rats, compared to controls, as shown in Fig. 9A . Furthermore, correlative immunohistochemistry ( Fig. 9B and 9C ) demonstrated dramatic increase of cathepsin D immunoreactivity, particularly in the retinal pigment epithelium (RPE) and ganglion cell layers (GCL), with only relatively low to moderate increased labeling in other layers of the neural retina, in AY9944-treated rats, compared to controls (see Discussion).
We further evaluated the involvement of caspase-3 activation in the observed retinal degeneration, which involves cleavage of procaspase-3 by initiator caspases to generate an active heterotetramer (48) . Fig. 10A shows that while the levels of procaspase-3 (M r ~ 35 kDa) were comparable in retinas from control and AY9944-treated rats, there was no detectable cleaved caspase-3 (M r ~ 19 kDa) in retinas under either condition. By contrast, cytochrome c-treated
Jurkat cell extracts (a positive control with low levels of cleaved caspase-3 (49)) exhibited the expected 19-kDa cleavage product, while untreated Jurkat cell extracts (the negative control) did not show this cleavage product, which validated the activity and sensitivity of the anti-cleavedcaspase antibody used in this study. Correlative immunohistochemistry, using the same anticleaved-caspase antibody on paraffin sections of retinas from AY9944-treated and control rats, exhibited no immunoreactivity ( Fig. 10B and 10C) . 
DISCUSSION
Decreased levels of cholesterol and elevated levels of 7DHC typically are observed in SLOS patients (1, 2). Fliesler et al. previously described a rat model of SLOS created by treatment of pregnant female rats with AY9944 during the second and third gestational weeks followed by the systemic injection of the progeny with the drug for up to three postnatal months (12, 13, 17) . In this model, gross elevation of 7DHC levels and reduction of cholesterol levels are detected in the blood, retina, liver and brain, and the extent of these biochemical alterations tends to be even greater than what is observed typically in SLOS patients. In the present study, to provide insight into molecular mechanisms underlying the observed retinal degeneration in the SLOS rat model and, by inference, to the human disease, we performed proteomic profiling of retinas of AY9944-treated rats in comparison with those from age-matched control rats. The following sections discuss both the well-controlled proteomics strategy and key discoveries derived therefrom.
Well-controlled, extensive and accurate ion-current-based profiling of the retinal proteomes in 10 animals
To achieve an extensive and confident discovery of the regulatory proteins that are potentially responsible for retinal degeneration in the SLOS model, it is critical to develop extensive, quantitative and reproducible procedures for sample preparation (especially for the membrane proteins in various subcellular compartments of the retina), analysis and quantification, and to minimize the extent of false-positives in discovering altered proteins.
In the present study we optimized a high-resolution and reproducible chromatographic strategy that permits an extensive and reliable quantification of the retinal proteome with 10
animals. An Orbitrap analyzer with an "overfilling" approach to enhance sensitivity without compromising MS accuracy and resolution (28) (29) (30) , was used to produce the precursor ion currents for quantification. Using a low-void-volume and reproducible nano-LC/nanospray
configuration modified from what we had developed previously (20, 29, 30, 39) , retinal samples were extensively resolved on a long, heated reversed-phase nano-LC column (75-cm-long, with 3-µm particles and heated at 52°C) with a shallow, 7-h gradient. A wide peptide elution window (>315 min) with an average peak width <30s (FWHM) and a peak capacity >600 was achieved, which enabled an in-depth profiling of the retinal proteome. The homogenous heating of the column and the use of a large-ID trap promotes efficient gradient mixing and dampened pump noise and thus allowing highly reproducible separation. Furthermore, regular rinsing of the spray tip (Experimental Procedures) considerably improved the reproducibility of the MS signal response. The level of reproducibility attained was a key factor in this study, which permitted reliable quantification using tissues obtained from 10 animals without the need of isotopic labeling. Evaluation data demonstrated the high quantitative precision and accuracy of the developed method (c.f. Fig. 2 and Supplement Fig. 1-4) . Moreover, compared to the spectral counting method, the ion current-based approach was observed to provide markedly lower quantitative variation and higher accuracy (which is particularly sound for low-abundance proteins), and reduced false discoveries for profiling of rat retina proteome. These results justified the use of the ion current-based method in this study. The reliability of proteomic quantification was further enhanced by the adoption of stringent criteria for identification and quantification were adopted, and that each quantifiable protein had independent, high-quality AUC data (e.g., S/N≥10) from at least 2 distinct peptides. cSREBP-1) and precursor forms of SREBP-1, and decreased levels of mature SREBP-2 (cSREBP-2) in retinas of AY9944-treated rats, compared to age-matched controls (Fig. 6) . These findings are consistent with a regulatory feedback mechanism by which the synthesis of cholesterol is decreased in order to reduce the levels of potentially cytotoxic molecules (e.g., 7DHC-derived oxysterols) (40), which recently have been shown to form and accumulate in tissues of the AY9944 SLOS rat model (41, 42) . Reduction of de novo biosynthesis of cholesterol in the retina of the SLOS rat model is suggested from the decreased cSREBP-2 levels. In addition, these findings would predict that metabolism of fatty acids and sphingolipids, in addition to sterols, may be affected in retinas of AY9944-treated rats. However, studies aimed at directly evaluating the rates of biosynthesis and turnover of fatty acids and sphingolipids in the retina in the SLOS rat model have not been reported; hence, we prefer to refrain from further speculation on this topic until such direct evidence becomes available.
Altered Lipid Metabolism in
Mammalian cells obtain cholesterol via two pathways: 1) endogenous de novo synthesis in the endoplasmic reticulum, and 2) through receptor-mediated uptake of exogenous, cholesterol-rich low density lipoproteins (LDL) (57, 58) . Though the mammalian retina has the capacity to synthesize its own cholesterol de novo (59, 60) , the steady-state levels of cholesterol both in the retina, as well in other tissues, are dramatically lower in the AY9944-treated rat model, compared to age-matched control rats (12, 13) . In this study, our proteomic results suggest that the retina can respond to diminished cholesterol levels and perturbations in cholesterol biosynthesis by down-regulating reverse cholesterol transport (e.g., to retain sterols within the retina) and modulating other cholesterol metabolism and transport proteins (61, 62) . For example, increased expression of A2M and haptoglobin, and decreased expression of PON1, ApoA1 and ApoE, as observed in the present study, potentially may reflect the retina's homeostatic attempt to recover normal cholesterol levels. ApoA1 and ApoE, the major protein components of high density lipoprotein (HDL), play an important role in the efflux of cellular cholesterol and phospholipids (63, 64) . PON1 also increases the HDL-mediated efflux of cholesterol, as previously reported (65) . Lecithin-cholesterol acyltransferase (LCAT), which converts free cholesterol to cholesterol esters with fatty acid from the sn-2 position of phosphatidylcholine (PC), is of critical importance in reverse cholesterol transport (66) . ApoA1 and ApoE are also the major activators of LCAT on apolipoprotein B-containing lipoproteins (67, 68) . Moreover, the enzymatic activity of LCAT can be inhibited by its binding to alpha-2-macroglobulin (69). In addition, it has been demonstrated that haptoglobin inhibits the reverse transport of cholesterol by preventing ApoA1 stimulation of LCAT activity (70) . In sum, these observations suggest that, in response to cholesterol deficiency, retinal cells in AY9944-treated rats strive to recover normative cholesterol levels while also reducing the levels of potentially toxic sterol precursors (or toxic compounds subsequently derived from those precursors) by suppression of sterol biosynthesis.
Cell Death Pathway and Retinal Degeneration in SLOS.
Retinal degeneration, both inherited and induced, is characterized by a loss of vision due to death of photoreceptors. Programmed cell death (or "apoptosis") is a common pathway in most, if not all, known examples of photoreceptor loss both in humans and in animal models (71) . The initial molecular basis of retinal degeneration in the SLOS rat model employed in this study is clear, as are the attendant histopathological and electrophysiological defects, which are comparable to or worse than those in the human disease (12) . In this study we further confirmed photoreceptor cell death in this model, as evidenced by the massive extent of TUNEL-positive labeling in the ONL (Fig. 7) . In addition, marked increase of GFAP, a sensitive marker for gliotic reactivity in retinal degeneration, also was detected with proteomic profiling and validated by immunohistochemistry (Fig. 8) . Despite these observations, the specific kind of cell death (e.g., apoptosis, necrosis, necroptosis, etc.) involved and a detail accounting of molecular changes beyond those involved in cholesterol biosynthesis remained elusive. Both caspase-dependent and caspase-independent pathways have been implicated in retinal cell death, and there is still debate regarding which pathways may be involved, depending where caspase-3 had been concomitantly knocked out (76) . Caspase-independent photoreceptor cell death also has been described in retinal degeneration induced by exposure to intense constant light (i.e., the "retinal light-damage" paradigm), and further studies show that this light-driven paradigm activates a caspase-independent pathway involving cathepsin D (72, 77) . In addition, studies employing z-VAD-fmk, a broad-spectrum caspase inhibitor, failed to demonstrate protection of photoreceptor cells from dying in the retinal light-damage model (49) .
In the present study, we observed highly elevated levels of cathepsin D, clusterin, HSPB1, and Stat3, which collectively are consistent with caspase-3-independent cell death in retinas in the SLOS rat model. Cathepsin D has been implicated in a caspase-independent cell death pathway in light-induced retinal degeneration models (77); moreover, clusterin was shown to contribute to caspase-3-independent neuronal death (78). Stat3 has been reported to regulate a lysosomalmediated pathway of cell death under physiological conditions independent of caspase-3 (79, 80).
HSPB1 was observed to delay release of cytochrome c from mitochondria and thus inhibiting the activation of caspase-3 (81) . Therefore, the elevation of these proteins suggests a caspase-3-independent cell death pathway in retinas from AY9944-treated rats. To validate this hypothesis (which was based upon proteomic data), we investigated the activation (cleavage) of caspase-3, using Western blot and correlative IHC analysis with an antibody immunospecific for cleaved caspase-3 that also has been validated as reactive in multiple species, including rat. As shown in In addition to caspases, the cathepsins  a family of cysteine, aspartate and serine proteases have been implicated in regulation of programmed cell death (46, 82) . Proteomics profiling detected significantly elevated levels of cathepsin D in retinas of AY9944-treated rats, which was further validated by Western blot and correlative IHC. Levels of pro-cathepsin D isoforms, the intermediate form, and mature enzyme, were all notably higher in retinas of AY9944-treated rats, compared to controls, as shown in Fig. 9A . Cathepsin D also has been reported to cleave and activate Bax, resulting in the selective release of apoptosis-inducing factor from mitochondria and induction of caspase-independent apoptosis (83) . Therefore, by regulating apoptosis, the elevated cathepsin D levels in retinas of AY9944-treated rats may play a role in the SLOS model retinal degeneration. However, as shown in Fig. 9C , while cathepsin D imunoreactivity was moderately higher throughout the neural retina, RPE and ganglion cells, the intensity was not higher in photoreceptors. As noted above, TUNEL-positive cells (Fig. 7) were found almost exclusively in the ONL, whereas there was no TUNEL labeling observed in the RPE or ganglion cell layers, indicating that those two cell types do not undergo appreciable cell death in this animal model (at least within the time window evaluated). Hence, the increase of cathepsin D in RPE and ganglion cells may be involved in cytoprotection, rather than in promoting cell death in this rat model of SLOS. In this regard, autophagy may be involved, affording these cell types a means to degrade damaged intracellular organelles and make new ones, rather than go down the path of cellular dysfunction, degeneration and eventual death (84, 85) .
Moreover, Stat3 was found to be elevated in retinas of AY9944-treated rats, relative to controls (Supplemental Fig. 7 ). Stat3 is a member of a family of cytokine-activated signaling molecules that can directly bind to DNA and modulate transcription of target genes. Aberrant expression of Stat3 has been implicated in regulation of cell proliferation, differentiation, transformation and apoptosis (86) . Furthermore, constitutive activation of Stat3 has been detected in various cancers and also has been shown to attenuate caspase-3-dependent apoptosis (87, 88) .
In addition, it has been demonstrated that Stat3 up-regulates the expression of cathepsins B and L, and controls lysosomal-mediated cell death independent of executioner caspases-3, -6 and -7 (79).
Therefore, we initially speculated that elevated expression of Stat3 in the retinas of AY9944-treated rats conceivably could play a regulatory role in determining the mode of cell death in the SLOS model retinal degeneration, driving the process toward a caspase-3-independent pathway, as suggested by the results discussed above. Furthermore, while cathepsin L was not quantified, cathepsin B was found significantly elevated in retinas of AY9944-treated rats (AY9944-treated/control = 1.5-fold, p < 0.01). This observation was also consistent with a caspase-3-independent cell death mechanism in the SLOS rat model.
Visual system development and function. Previous studies showed that progressive retinal degeneration in the AY9944-treated rat model of SLOS was characterized by shortening of photoreceptor outer segments, pyknosis and thinning of the ONL, and electrophysiological abnormalities involving both rod and cone photoreceptors (12, 13) . In the present study, we observed altered expression levels of 9 proteins related to visual system development and function in the retinas of AY9944-treated rats, relative to age-matched controls (Supplemental Table IV ). Among these, the level of rhodopsin kinase (GRK1) was reduced by 1.3-fold; GRK1
regulates the phototransduction cascade in the ROS by phosphorylating the light-activated visual pigment rhodopsin (RHO), which in turn promotes the binding of phospho-RHO to arrestin and prevents its further interaction with its cognate G-protein, transducin (Gt), thereby shutting off the visual transduction cascade (89) . The guanine nucleotide binding protein alpha-transducin 3 (GNAT3; also known as "gustducin") also was observed to be decreased nearly 2-fold; this protein, originally associated with transduction mechanisms involved in the sensation of taste (90), more recently has been found to exist in mammalian retinas (91) . The level of phosducin (PDC), which regulates the phototransduction cascade by interacting with transducin (92), also was found to be reduced by 1.6-fold. Peripherin-2 (also known as "rds"), which plays a key role in the formation of photoreceptor outer segment disks and mutations in which are responsible for various retinal degenerative diseases (93), also was decreased (1.5-fold) in retinas from AY9944-treated rats. In sum, the decreased levels of phototransduction-associated proteins found in this study are consistent with previous studies that have documented the visual dysfunction and concomitant retinal degeneration in the SLOS rat model.
In conclusion, herein we developed and then applied a reproducible and well-controlled ion current-based strategy for the comparison of retinal proteomes from AY9944-treated rats vs. agematched controls. We discovered a myriad of changes in the expression levels of an expansive and diverse set of cellular proteins in the SLOS rat model of retinal degeneration, with high confidence. These molecular changes are predicted to have a significant impact on multiple biological processes and physiological functions, including lipid metabolism, oxidative stress response, cell death, proteolysis, visual transduction, and transport, consistent with the retinal degeneration observed in this animal model. Hence, to the extent that this pharmacologicallyinduced rat model faithfully represents the underlying mechanism of the human genetic disorder, the pathobiology of the SLOS goes well beyond the initial defect in cholesterol biosynthesis per se, as previously suggested (43) . Moreover and beyond this, the proteomic strategies employed in this study represent technical advancements that may be applied more broadly to studying differences in protein expression in a wide variety of biological systems. Fig. 1 . Scheme of proteomics strategy applied to analysis of retinas from AY9944-treated vs.
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age/sex-matched control (untreated) rats (N=5 animals per group). A highly reproducible and extensive ion current-based quantification method was optimized and applied in the analysis of the 10 biological replicates. The quantitative variation of the proteomics strategy was evaluated using a sham sample set, which consisted of identical aliquots of a pooled sample that were analyzed in an order randomly interleaved with the analysis of the biological samples. Fig. 1 . Scheme of proteomics strategy applied to analysis of retinas from AY9944-treated vs. age-matched control rats (N=5 animals per group). A highly reproducible and extensive ion current-based quantification method was optimized and applied in the analysis of the 10 biological replicates. The quantitative variation of the proteomics strategy was evaluated using a sham sample set, which consisted of identical aliquots of a pooled sample that were analyzed in an order randomly interleaved with the analysis of the biological samples. 
